Dr. Reddy's Laboratories Files Routine 6-K Report
Ticker: RDY · Form: 6-K · Filed: Nov 6, 2024 · CIK: 1135951
| Field | Detail |
|---|---|
| Company | Dr Reddys Laboratories LTD (RDY) |
| Form Type | 6-K |
| Filed Date | Nov 6, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, 6-K
TL;DR
DRL filed a 6-K, just routine paperwork, nothing new to see here.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on November 6, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or material events beyond its routine reporting status.
Why It Matters
This filing indicates Dr. Reddy's Laboratories is fulfilling its ongoing reporting obligations as a foreign private issuer with the SEC.
Risk Assessment
Risk Level: low — The filing is a standard report of a foreign private issuer and does not disclose any new material risks or events.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Filer of the report
- SEC (company) — Recipient of the filing
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public pursuant to the laws of their home country, or that they have filed or are required to file with a stock exchange on which their securities are traded.
When was this Form 6-K filed?
This Form 6-K was filed on November 6, 2024.
What is the period of report for this filing?
The conformed period of report for this filing is November 5, 2024.
What is the principal executive office address of Dr. Reddy's Laboratories Limited?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does this filing indicate Dr. Reddy's Laboratories is submitting the Form 6-K in paper format?
The filing includes check boxes for submitting in paper as permitted by Regulation S-T Rule 101(b)(1) and 101(b)(7), but it does not indicate that the registrant is actually submitting in paper.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-11-06 06:05:03
Filing Documents
- drr0690_6k.htm (6-K) — 14KB
- drr0690_ex99-1.htm (EX-99.1) — 6KB
- drr0690_img01.jpg (GRAPHIC) — 4KB
- drr0690_img02.jpg (GRAPHIC) — 5KB
- 0001575872-24-001125.txt ( ) — 33KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: November 5, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3